OverviewSuggest Edit

Transcenta is a biotherapeutics company that integrates antibody-based biotherapeutics discovery, R&D, and manufacturing. It is engaged in the development of molecules in oncology, bone disorders, and nephrology.


Latest Updates

Employees (est.) (Jun 2020)60(+2%)

Key People/Management at Transcenta

Xueming Qian

Xueming Qian

Co-Founder & CEO
Jonathan Zhao

Jonathan Zhao

Co-Founder & Executive Chairman
Chris Hwang

Chris Hwang

Chief Technology Officer
Frank Ye

Frank Ye

Chief Operating Officer
Jerry Yang

Jerry Yang

SVP, Process Development
Jason Huang

Jason Huang

SVP, Clinical Development
Show more

Transcenta Financials and Metrics

Summary Metrics

Founding Date


Transcenta total Funding

$100 m

Transcenta latest funding size

$100 m

Time since last funding

5 months ago

Transcenta investors

Transcenta's latest funding round in January 2020 was reported to be $100 m. In total, Transcenta has raised $100 m
Show all financial metrics

Transcenta Online and Social Media Presence

Embed Graph

Transcenta Frequently Asked Questions

  • When was Transcenta founded?

    Transcenta was founded in 2019.

  • Who are Transcenta key executives?

    Transcenta's key executives are Xueming Qian, Jonathan Zhao and Chris Hwang.

  • How many employees does Transcenta have?

    Transcenta has 60 employees.

  • Who are Transcenta competitors?

    Competitors of Transcenta include Vitality Biopharma, Opiant Pharmaceuticals and Mylan.